Isabelle de Cremoux

Isabelle de Cremoux is currently Chief Executive Officer & Managing Partner at Seventure Partners SA (Investment Management) since 2011 and CEO & Managing Partner at Seventure Partners SA since 2011.
Current roles also include Director positions at Enterome SA (since 2008), YSOPIA Biosciences SA (since 2015), TargEDys SA, The Akkermansia Co., Iome Bio SA, and Independent Director at Robertet SA (since 2023).
Holds the title of Non-Independent Non-Executive Director at Maat Pharma SA (since 2014) and Managing Partner at both Ms. de Cremoux SAS and Health for Life Management.
Former roles include Director-Business Development at Laboratoires Fournier SAS from 1998 to 2009, Independent Director at Givaudan France Naturals SAS from 2015 to 2018, and Director positions at MERISTEM Therapeutics SA, Vivostat A, Fluxome Sciences A, Biophytis SA, Polaris SA, Nutrionix SA, LiMM Therapeutics SA, as well as Principal roles at Arthur Andersen LLP and Pfizer, Inc. Education includes undergraduate studies at École Centrale Paris.